licensing
Why you need AI to manage increasing global complexity
February 12 by Pharma IQHow AI is enabling pharmaceutical companies to make smarter decisions and stay ahead of the competition
Hands Off my Data: How to Protect Sensitive Information in the Biotech Industry
August 16 by Pharmaceuticals & Biotechnology EditorIntellectual property is the life sciences industry’s most important asset, because it forms the basis of product approvals and of cooperation, licensing and due diligence negotiations. That i...
Providing Compliant Regulatory Submissions
December 24 by Andrea CharlesMickel Hedemand, Internal Advisor, Licensing Division at the Danish Medicines Agency, spoke to Andrea Charles from Pharma IQ, about the commonest reasons why companies fail first time...
What are the Requirements for Establishing a Data Network Collaboration?
October 05 by Pharma IQIn this interview Jos van den Heuvel, Director of External Manufacturing at Janssen Pharmaceutica NV, Johnson & Johnson, speaks to Rebecca Maschke from Pharma IQ, about supplier integr...
3rd Party Integration: Mitigating Risks
August 26 by Pharma IQIn this interview Béatrice Serckx, Associate Director, Drug Production Industrial Strategy and CMO Management, UCB Pharma, speaks to Andrea Charles from Pharma IQ, about the hurdles to succes...